Adjuvant Tumor Lysate Vaccine and Iscomatrix With or Without Metronomic Oral Cyclophosphamide and Celecoxib in Patients With Malignancies Involving Lungs, Esophagus, Pleura, or Mediastinum

Clinical trial NCT02054104 · TERMINATED

Trial details

NCT number: NCT02054104
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Thoracic Sarcomas Thorasic Cancers Cancers of Non-thoracic Origin With Metastases to the Lungs or Pleura Sarcoma Melanoma

Start date: 2014-09-03
Primary completion: 2015-06-03
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.